Imagion Biosystems
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 Albert Rd L 4, South Melbourne, Vict...Website
www.imagionbiosystems.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Imagion Biosystems
Imagion Biosystems is a clinical-stage medical imaging company specializing in molecular MRI technology to enhance early and precise cancer detection. Their flagship product, MagSense, utilizes bio-safe magnetic nanoparticles to identify cancer biomarkers, enabling the detection of tumors as small as 12 mm. The technology aims to improve diagnostic accuracy for various cancers, including HER2-positive breast cancer, prostate cancer, and ovarian cancer, while reducing the need for invasive procedures. Currently, the company is preparing for Phase II clinical trials to further evaluate the effectiveness of their imaging agents.Explore more
Imagion Biosystems Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Imagion Biosystems your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Imagion Biosystems has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Imagion Biosystems launches new products
Imagion Biosystems, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Imagion Biosystems recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Imagion Biosystems
Click to see if Imagion Biosystems had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Imagion Biosystems has new funding data
Check out if Imagion Biosystems is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Imagion Biosystems as Masked Content
Find 2 more new buyers
Compare Similar Companies to Imagion Biosystems
Compare insights from companies similar to Imagion Biosystems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Imagion Biosystems is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Imagion Biosystems is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Imagion Biosystems.
Imagion Biosystems financials insights
Gather financial insights about Imagion Biosystems, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$3M
Imagion Biosystems Tech Stack
A closer look at the technologies used by Imagion Biosystems
Most Recent Scoops
Funding
Funding
Open Position
Imagion Biosystems is currently seeking a Director, Quality Assurance. (San Diego, CA)
Promotion
Promotion
Executive Move
Promotion
Left Company
Executive Move
Imagion Biosystems News & Media
Imagion Biosystems Boosts Funding and Secures Licensing Deal - TipRanks.com
Imagion Biosystems Ltd. (AU:IBX) has released an update. Imagion Biosystems Ltd. has secured $3 million in new funding through a share placement led by CPS Capital,...Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent
MELBOURNE, Australia and SAN DIEGO, Dec. 13, 2023 /PRNewswire/ -- Imagion Biosystems Limited (ASX: IBX) recently announced positive results following completion of the IBI10103 phase I clinical trial evaluating the safety and clinical feasibility of MagSense® HER2 Imaging Agent (MSH2IA)...Imagion Biosystems Secures AU$3.5 Million R&D Tax Rebate for Fiscal Year 2022
-- Imagion Biosystems secured a AU$3.5 million rebate for the fiscal year ended June 30, 2022 from the Australian government’s research and development tax incentive scheme. The refund is higher...Imagion Expands Collaboration with Siemens Healthineers to United States
NEW YORK--(BUSINESS WIRE)--Manhattan Scientifics Inc. (OTC: MHTX ), announces that Siemens & Imagion Biosystems (IBX:ASX) collaborate. U.S. Founder MHTX owns 50 million Shares of Imagion Biosystems. For further details, please see Imagion Biosystems Press Release About Manhattan Scientifics, Inc. Manhattan Scientifics Inc. (www.mhtx.com) is focused on technology transfer and commercialization of transformative technologies. About Imagion Biosystems Imagion Biosystems (www.imagionbiosystems.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Imagion Biosystems
Sign Up For FreeTo access detailed company insights
Imagion Biosystems is a clinical-stage medical imaging company specializing in molecular MRI technology to enhance early and precise cancer detection. Their flagship product, MagSense, utilizes bio-safe magnetic nanoparticles to identify cancer biomarkers, enabling the detection of tumors as small as 12 mm. The technology aims to improve diagnostic... Read More
